Searched for
RANBAXY STOCKS
Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Negative view on Ranbaxy: Daljeet Singh KohliYou do not get enough information from Ranbaxy. This is in contrast with other pharma companies, which provide sufficient information, Kohl...
- Ranbaxy stock up 50% post deal with Sun Pharma; co grabs 13% market share after Diovan’s launchUnder the terms of the acquisition, for every five shares held in Ranbaxy, shareholders are going to receive four of Sun Pharma.
- SC asks Andhra HC to decide on Ranbaxy-Sun Pharma mergerTwo individual investors alleged that there was heavy trading of Ranbaxy stock before the merger with Sun Pharma was announced on April 6.
- Andhra Pradesh High Court puts on hold Sun-Ranbaxy deal till insider trade verdictShares of Ranbaxy, which is majority-owned by Japan’s Daiichi-Sankyo, saw an unusual increase in price and turnover during six trading days...
- Buy Sun Pharma shares through RanbaxyAn investor who is really confident that the deal will go through can buy Ranbaxy shares and pocket the difference when the merger is compl...
- Did D-Street had an inkling of Ranbaxy deal with Sun Pharma?Creation of sizeable derivative bets on Ranbaxy last week raised questions about whether some influential traders had an inkling of its dea...
- Pharma CEO kin stocking up on Ranbaxy sharesThe relative of the CEO of one of India’s biggest pharma companies from buying the stock in the market.
- Institutional investors cut their exposure on Ranbaxy stockInstitutional Investors of Ranbaxy sell their shares, as challenges over future first to file looms over the company.
- Ranbaxy should be squared off by end of day: Deepak Mohoni"In the short sales, there is Ranbaxy, stock that has started floundering a little bit in this decline and it is day trade, should be squar...
- Short sell Ranbaxy stock: Deepak MohoniThe stock has been struggling a bit lately and this is purely a day traded does not go overnight.
- Buy Ranbaxy on declines: Devang VisariaET Now spoke to Devang Visaria, Chief Strategist, devangvisaria.com, on his views on the Ranbaxy stock.
- Any downside would be an opportunity to buy Ranbaxy: Sunil ShahET Now spoke to Sunil Shah, Director Equities, Indsec Securities and Finance on his views on the Ranbaxy stock.
- Global giant out to ruin deal: RanbaxyRanbaxy CEO and MD Malvinder Singh said that a big global pharma company was trying to scuttle the deal with Daiichi Sankyo.
- Daiichi in focus as Ranbaxy stock goes on free fallThe trigger for battering of Ranbaxy stock has been largely driven by news reports that the US Department of Justice has levelled charges a...
- All eyes on Daiichi as Ranbaxy stock goes on a free fallThe stock on June 10 - a day before the announcement - closed at Rs 560.75 implying that the Japanese acquirer was paying a premium of over...
- Tax sword hangs over Ranbaxy-Daiichi dealA stock exchange transaction will result in the promoters saving more than Rs 1,000 cr, which they would have to pay if this was an off-mar...
- Ranbaxy clears R&D demerger schemeRanbaxy Laboratories has approved the demerger of its new drug discovery research unit into a subsidiary, Ranbaxy Life Science Research.
- Ranbaxy stock slides on raids on US officesThe Ranbaxy share price dropped 5% on Thursday in the backdrop of US federal officials conducting a search on the premises of the company’s...
Load More
